It seems to me that it is likely that they are still in the process of discussions. If they werent why wouldnt they issue a release?The only other thing I could imagine is maybe they want some PR over the weekend.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%